Cognito Therapeutics
Cambridge, US · Incorporated in Cayman Islands · 1 known investors
Find your way into Cognito Therapeutics
Sign up to see every warm intro you have to Cognito Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cognito Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
BV

Brent VaughanExecutiveBrent Vaughan is an executive officer and director at Cognito Therapeutics who previously held roles at Lilly, Roche, Novartis, and Nektar, where he worked on drug development and commercialization across CNS, cardiometabolic, and oncology indications. He holds patents in AI/ML and optogenetics applications for CNS diagnosis and treatment.
Board
HL

SB
Stephen BrusoBoard director
JH
Jeffrey HalisBoard director
GC
Gerald ChanBoard director
RK
Richard KuntzBoard director
LB
Laura BregeBoard director
Investors · 1
FoundersX VenturesreportedSilicon Valleyvia Helen Liang · board
How we know: a partner's Signal profile · board seat on SEC Form D · funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$224M disclosed across 3 of 4 rounds · 2022–2026
- $105MSeries CMar 2026 · 3 sourcesSource ↗
▶$10.2MraisedJul 2024 · 3 investors · Other Health CareRule 506(b)
▶$10.2MraisedJul 2024 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brent VaughanExecutive Officer, Director
- Helen LiangDirector
- Stephen BrusoDirector
- Jeffrey HalisDirector
- Gerald ChanDirector
- Richard KuntzDirector
- Laura BregeDirector
- Offering amount
- $60M
- Amount sold
- $10.2M
- First sale
- Jun 2024
- Incorporated
- Other, Cayman Islands
- Federal exemptions
- 06b
▶$108.8MraisedNov 2023 · 13 investors · Other Health CareRule 506(b)
▶$108.8MraisedNov 2023 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brent VaughanExecutive Officer, Director
- Gerald ChanDirector
- Helen LiangDirector
- Stephen BrusoDirector
- Richard KuntzDirector
- Offering amount
- $126.2M
- Amount sold
- $108.8M
- First sale
- Jun 2022
- Incorporated
- Other, Cayman Islands
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Cognito Therapeutics went on to found or lead other companies.
Frequently asked questions
- Who are Cognito Therapeutics's investors?
- Cognito Therapeutics's investors include FoundersX Ventures.
- How much funding has Cognito Therapeutics raised?
- Cognito Therapeutics has disclosed $224M raised across 3 of its 4 known rounds.
- Where is Cognito Therapeutics headquartered?
- Cognito Therapeutics is headquartered in Cambridge, US.
